Matthew R Chang

4PUBLICATIONS
18CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 27, 2024
Anti-CD99 Antibody Therapy Triggers Macrophage-Dependent Ewing Cell Death In Vitro and Myeloid Cell Recruitment In Vivo.

Allison F O'Neill, Evelyn M Nguyen, Evelyn D Maldonado

|Aug 10, 2023
The variable conversion of neutralizing anti-SARS-CoV-2 single-chain antibodies to IgG provides insight into RBD epitope accessibility.

Matthew R Chang, Hanzhong Ke, Laura Losada Miguéns

|Oct 03, 2022
IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern.

Matthew R Chang, Luke Tomasovic, Natalia A Kuzmina

|Sep 23, 2022
Immune Evasion of SARS-CoV-2 Omicron Subvariants.

Hanzhong Ke, Matthew R Chang, Wayne A Marasco

Pageof 1